Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan

BACKGROUND: Acute exacerbation is a life-threatening event in patients with fibrosing interstitial lung diseases (ILDs). Although nintedanib reduces acute exacerbation incidence, its effectiveness during acute exacerbation is unclear. METHODS: Using data from the Diagnosis Procedure Combination data...

Descripción completa

Detalles Bibliográficos
Autores principales: Urushiyama, Hirokazu, Jo, Taisuke, Hasegawa, Wakae, Yokoyama, Akira, Ando, Takahiro, Sakamoto, Yukiyo, Kumazawa, Ryosuke, Uda, Kazuaki, Michihata, Nobuaki, Awano, Nobuyasu, Hiroki, Matsui, Fushimi, Kiyohide, Yasunaga, Hideo, Nagase, Takahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703144/
https://www.ncbi.nlm.nih.gov/pubmed/36451844
http://dx.doi.org/10.1183/23120541.00209-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703144/
https://www.ncbi.nlm.nih.gov/pubmed/36451844
http://dx.doi.org/10.1183/23120541.00209-2022

Ejemplares similares